Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1108 of 1,261
  1. US 7070957

    STARS—a muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  2. US 7071318

    Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

    The Board of Regents of the University of Texas System · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  3. US 7071224

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  4. US 7070975

    Protein and DNA thereof

    Takeda Chemical Industries Ltd. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  5. US 7070973

    Butyrylcholinesterase variants and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  6. US 7070972

    Janus family kinases and identification of immune modulators

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  7. US 7070805

    Rapidly disintegrable solid preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  8. US 7070956

    Peptides and derivatives thereof showing cell attachment, spreading and detachment activity

    REGENBiotech, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  9. US 7071205

    5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  10. US 7071200

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  11. CA 2591889

    TRAITEMENT DE LA DEPRESSION MELANCOLIQUE SEVERE A L'AIDE D'EPA

    AMARIN NEUROSCIENCE LTD [GB] · Granted Jun 29, 2006 · Expires Jun 24, 2026

    granted
  12. US 7067317

    Regulation of angiogenesis with zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  13. US RE39146

    Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof

    BRACCO INT BV [NL] · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  14. US 7067653

    Porphyrin Based neuton capture agents for cancer therapy

    The Regents of the University of California · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  15. US 7067661

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  16. US 7067633

    Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  17. US 7067546

    Crystal and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  18. US 7067537

    Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  19. US 7067483

    Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  20. US 7067481

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  21. US 7067111

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  22. US 7067256

    Ribozyme mediated inactivation of the androgen receptor

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  23. US 7067122

    Modified live Edwardsiella tarda vaccine for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  24. US 7067254

    Diagnosis and treatment of inflammation and hyperactive immune conditions

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.